Delivery Order SPE2DR25D3301-SPE2DR26F20AU
- Not listed
- The Defense Logistics Agency awarded a $35,205.19 delivery order to AmerisourceBergen Drug Corp for Sunitinib Malate 25 mg capsules (28-count packaging) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be performed and shipped...
- The Defense Logistics Agency awarded a delivery order valued at $37,245.18 to AmerisourceBergen Drug Corp for the supply of Sunitinib Malate 25 mg capsules (28-count units). This competitively awarded contract, issued on September 25, 2025, with a completion date of September 26, 2025, represents a firm fixed price delivery order with no set-aside designation. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $22,883.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for Sunitinib Malate 37.5 mg capsules (28-count packaging) on September 22, 2025, with completion targeted for September 23, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contract vehicle,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count) with a ceiling value of $9,141.79. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count units) with a ceiling value of $11,228.08. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract vehicle. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025, and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,615.45 firm fixed-price contract is for the delivery of Sunitinib Malate 37.5 mg capsules, a specialty medication. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive...
- This is a delivery order from the Defense Logistics Agency (DLA) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Sunitinib Malate 25 mg capsules. The order, valued at $37,567.48, has a firm fixed price pricing type and an ultimate completion date of August 14, 2024. The contract does not have a set-aside designation. As a large pharmaceutical supplier, AmerisourceBergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,069,681 units of the drug Sunitinib Malate 25 mg capsules. The firm-fixed-price contract has a ceiling value of $44,697.73 and a completion date of November 14, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Sunitinib Malate 50 mg capsules (quantity 28) with a ceiling value of $11,179.35. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 pharmaceutical prime vendor agreement running through December 2026. The contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $11,811.11 contract is for the supply of Sunitinib Malate 50 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was previously awarded solely to AmerisourceBergen Drug Corp. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20AUDelivery Order
The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sunitinib Malate 37.5 mg capsules (28-count packages) under a firm fixed-price contract valued at $11,166.94. The delivery order was awarded on December 30, 2025, with an ultimate completion date of December 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This competitively awarded contract includes no set-aside designation, reflecting AmerisourceBergen's capability to compete openly for federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other government entities. The broader IDC enables the company to deliver specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains to support global military healthcare operations through the Defense Health Agency and affiliated government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 12/29/25 |